Metformin a potential pharmacological strategy in late onset Alzheimer’s disease treatment

Review

Abstract: Alzheimer’s disease (AD) is one of the most devastating brain disorders. Currently, there are no eff

Palabras claves:

Alzheimer’s disease, AMP activated protein kinase AMPK, Beta amyloid, diabetes mellitus, Insulin Resistance, Metformin, Tau protein hyperphosphorylation

Autores:

Antoni Camins, Cano A., Ettcheto M., Javan M., Manzine P.R., Olloquequi J., Poor S.R., Sanchez-Lopez E.

Fuentes:

scopus